PLAUR and Miyoshi myopathy: Based on the analyses of the control group, including 12 participants without malignant disease, versus the group of MM patients (N = 21; 15 EM and 6 BM) and 13 patients with lung cancer, we observed significantly increased serum uPAR levels in the MM patients.